Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical data trend for Akso Health Group's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:8HX1 vs ACH, FOCL, YI: FCF Margin % Comparison
For the Medical Distribution subindustry, Akso Health Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akso Health Group FCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Akso Health Group's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Akso Health Group's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akso Health Group (STU:8HX1) has a FCF Margin % of -205.23% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Akso Health Group and its competitors. According to the industry distribution chart, Akso Health Group ranks #117 out of 117 companies in the Medical Distribution industry.
Is Akso Health Group's FCF Margin % too high?
Akso Health Group's current FCF Margin % is -205.23%. Based on the distribution chart, Akso Health Group ranks #117 out of 117 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Akso Health Group has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Akso Health Group's FCF Margin % compare to ACH and FOCL?
According to the Medical Distribution industry distribution chart, Akso Health Group ranks #117 out of 117 companies for FCF Margin %. This places Akso Health Group in the lower half of its industry. The industry median FCF Margin % is 0.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 0.60, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Akso Health Group and its competitors. For the Medical Distribution industry, the median FCF Margin % is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akso Health Group's current FCF Margin % is -205.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akso Health Group stock overvalued right now?
Akso Health Group (STU:8HX1) has a current FCF Margin % of -205.23%. The stock's GF Value™ is €0.32, compared to a current price of €1.20 — trading 275% above its estimated fair value. The current FCF Margin % is -205.23%. Akso Health Group's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Akso Health Group (STU:8HX1), the current FCF Margin % is -205.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Akso Health Group (STU:8HX1) Overvalued in 2026?
Based on GuruFocus' analysis, Akso Health Group stock appears to be overvalued.
The current stock price of €1.20 is trading 275% above its estimated GF Value™ of €0.32.
Key valuation signals for STU:8HX1:
FCF Margin %: -205.23%
GF Value™: €0.32 vs. price of €1.20 (275% above fair value)
No single metric tells the full story. See the STU:8HX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
36GF Score
Get the complete analysis for STU:8HX1
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:8HX1 has been successfully added to your 
